The company's technology enhances the transport of medication by exploiting intestinal transporter proteins as carriers for drug conjugates, improving the impact of drug treatment. They chemically attach a nutrient mimic to the drug, which is recognized by the intestinal wall and facilitates active transport. With their patented technology, PharmaCytics addresses issues around oral bioavailability and provides control over the compound. They have also developed a toolbox of linkers and nutrient mimics, allowing for the coupling of drugs to biomolecules and the creation of mutual prodrugs. PharmaCytics offers their expertise in medicinal chemistry, prodrug technology, and drug delivery to solve drug development issues and revive promising but shelved research in the pipeline.